Sudden Sensorineural Hearing Loss Treatment

Initial Treatment

The American Academy of Otolaryngology-Head and Neck Surgery recommends that initial treatment of sudden sensorineural hearing loss should consist of oral or intratympanic corticosteroids, started as soon as possible within the first 2 weeks of symptom onset 1
The choice between oral and intratympanic corticosteroids may be based on potential side effects (88% with oral therapy vs 90% with intratympanic therapy) 2
The American Academy of Otolaryngology-Head and Neck Surgery suggests that treatment should be initiated promptly, ideally within the first 2 weeks of symptom onset, for better outcomes 1

Patients with moderate to severe hearing loss (>60 dB) may benefit from early treatment (within 2 weeks to 3 months) 2
Younger patients (under 50-60 years) may have better outcomes with early treatment 2
The American Academy of Otolaryngology-Head and Neck Surgery recommends that patients who do not respond to initial treatment may be considered for intratympanic corticosteroids or hyperbaric oxygen therapy combined with corticosteroids within the first month 1

The American Academy of Otolaryngology-Head and Neck Surgery suggests that patients with persistent hearing loss may be considered for conventional hearing aids, CROS systems, BiCROS systems, bone-anchored hearing devices, or cochlear implants in selected cases of severe to profound hearing loss 1
Serial audiometry should be performed to monitor recovery, and auditory rehabilitation should be provided for residual hearing loss 1

The impact of unilateral hearing loss on quality of life is significant and should not be underestimated 1
86% of patients with unilateral hearing loss report auditory disability 1
It is essential to provide counseling on treatment options, potential outcomes, and rehabilitation options 1